Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Rigel Pharmaceuticals Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 126 | 169 | +43 |
| Shares | 13.9M | 15.0M | +1.13M (+8.1%) |
| Value | $260.2M | $425.6M | +$165.4M (+63.6%) |
New holders (53)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (10)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Oconnor LLC | 104,890 | $1.96M |
| Carrera Capital Advisors | 50,299 | $942.1K |
| Jump Financial, LLC | 23,022 | $431.2K |
| PDT Partners, LLC | 19,809 | $371.0K |
| American Century Companies Inc | 16,935 | $317.2K |
| Connecticut Wealth Management, LLC | 11,520 | $215.8K |
| US Bancorp | 4,677 | $87.6K |
| RMG Wealth Management LLC | 2,205 | $41.5K |
| Clearstead Advisors, LLC | 58 | $1.09K |
| Rothschild Investment LLC | 10 | $187 |